These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Circulating endothelial cells, microparticles and progenitors: towards the definition of vascular competence]. Sabatier F; Lacroix R; Camoin-Jau L; Anfosso F; Sampol J; Dignat-George F Rev Med Interne; 2011 Jan; 32(1):54-63. PubMed ID: 20541851 [TBL] [Abstract][Full Text] [Related]
5. Microparticles as new markers of cardiovascular risk in diabetes and beyond. Santilli F; Marchisio M; Lanuti P; Boccatonda A; Miscia S; Davì G Thromb Haemost; 2016 Aug; 116(2):220-34. PubMed ID: 27173919 [TBL] [Abstract][Full Text] [Related]
6. Endothelial cell-, platelet-, and monocyte/macrophage-derived microparticles are elevated in psoriasis beyond cardiometabolic risk factors. Takeshita J; Mohler ER; Krishnamoorthy P; Moore J; Rogers WT; Zhang L; Gelfand JM; Mehta NN J Am Heart Assoc; 2014 Feb; 3(1):e000507. PubMed ID: 24584739 [TBL] [Abstract][Full Text] [Related]
7. Microparticles as biomarkers of vascular dysfunction in metabolic syndrome and its individual components. Agouni A; Andriantsitohaina R; Martinez MC Curr Vasc Pharmacol; 2014 May; 12(3):483-92. PubMed ID: 24846237 [TBL] [Abstract][Full Text] [Related]
8. Microparticles: a component of various diseases. Budaj M; Poljak Z; Ďuriš I; Kaško M; Imrich R; Kopáni M; Maruščáková L; Hulín I Pol Arch Med Wewn; 2012; 122 Suppl 1():24-9. PubMed ID: 23222474 [TBL] [Abstract][Full Text] [Related]
9. Subclinical markers of cardiovascular toxicity of benzene inhalation in mice. Malovichko MV; Abplanalp WT; McFall SA; Taylor BS; Wickramasinghe NS; Sithu ID; Zelko IN; Uchida S; Hill BG; Sutaria SR; Nantz MH; Bhatnagar A; Conklin DJ; O'Toole TE; Srivastava S Toxicol Appl Pharmacol; 2021 Nov; 431():115742. PubMed ID: 34624356 [TBL] [Abstract][Full Text] [Related]
10. Marathon running increases circulating endothelial- and thrombocyte-derived microparticles. Schwarz V; Düsing P; Liman T; Werner C; Herm J; Bachelier K; Krüll M; Brechtel L; Jungehulsing GJ; Haverkamp W; Böhm M; Endres M; Haeusler KG; Laufs U Eur J Prev Cardiol; 2018 Feb; 25(3):317-324. PubMed ID: 29183152 [TBL] [Abstract][Full Text] [Related]
11. Microparticles: targets and tools in cardiovascular disease. Martinez MC; Tual-Chalot S; Leonetti D; Andriantsitohaina R Trends Pharmacol Sci; 2011 Nov; 32(11):659-65. PubMed ID: 21794929 [TBL] [Abstract][Full Text] [Related]
12. The relationship between plasma microparticles and disease manifestations in patients with systemic sclerosis. Guiducci S; Distler JH; Jüngel A; Huscher D; Huber LC; Michel BA; Gay RE; Pisetsky DS; Gay S; Matucci-Cerinic M; Distler O Arthritis Rheum; 2008 Sep; 58(9):2845-53. PubMed ID: 18759303 [TBL] [Abstract][Full Text] [Related]